Amarin Corp Plc (AMRN)

[BioBS2012]

Given that the company has been selling Vascepa for a few years now not sure why one would expect more non-sales positions.
It is not unreasonable to expect existing suppliers to crank out more product. People handling that supply chain already exist
The accounting folks can surely handle the additional “katching” sound
Sales they have added more for now
Really need minimal additional nonsales personnel to get to a Billion in sales.
As sales ramp up they can assess and see where it makes most sense to add personnel
IMO management has been very prudent thus far and one can expect the same to continue